Episurf Medical (NASDAQ: EPIS B) today announces that the first Episealer® surgery in the US was performed yesterday. The surgery was performed by Dr. Doug Haltom, MD at the West Tennessee Bone & Joint Clinic in Jackson, Tennessee (Clinical Research Solutions, Jackson, TN), within the company's IDE Clinical Trial, EPIC-Knee: Episealer® Knee System IDE Clinical Study.
"The procedure went great today. Instrumentation worked extremely well. Excited about the future of this product and procedure" says Dr. Doug Haltom.
"This is, of course, a great milestone for us, and we would like to extend our gratitude to everyone involved. Many more surgeries are to come in the US, but the first surgery in the US is a special milestone for us", says Pål Ryfors, CEO Episurf Medical.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be cost-efficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.
(c) 2020 Cision. All rights reserved., source Press Releases - English